Literature DB >> 22363145

Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.

Wei He1, Ke Li, Feng Wang, Yan-Ru Qin, Qing-Xia Fan.   

Abstract

AIM: To explore the expression pattern of OCT4 in human esophageal squamous cell carcinoma and its significance in diagnosis and prognosis.
METHODS: Using real-time polymerase chain reaction (PCR), Western blotting, immunocytochemistry and immunohistochemistry, the expression of OCT4 in three esophageal squamous cancer cell lines, KYSE70, KYSE140 and KYSE450, was characterized. OCT4 expression was investigated in a series of 153 esophageal squamous cell carcinoma samples using immunohistochemistry and explored its association with clinicopathological features.
RESULTS: Immunohistochemically, OCT4 positive immunostaining was observed in cancer cell nuclei. OCT4 was variably expressed in three esophageal squamous cancer cell lines. Among 153 specimens, 105 (68.7%) were negative or weakly positive for OCT4 staining; 21 (13.7%) were moderately positive and 27 (17.6%) were strongly positive. Higher expression level of OCT4 was significantly associated with higher histological grade (P < 0.001) and poor clinic outcome (P < 0.001).
CONCLUSION: The expression of OCT4 enables the tumor to have a higher degree of stemness, which in turn results in a poorer clinical outcome for patients with esophageal squamous cell carcinoma.

Entities:  

Keywords:  Esophageal squamous cell carcinoma; Immunohistochemistry; OCT4; Real-time polymerase chain reaction; Western blotting

Mesh:

Substances:

Year:  2012        PMID: 22363145      PMCID: PMC3281231          DOI: 10.3748/wjg.v18.i7.712

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  33 in total

1.  Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells.

Authors:  Sayaka Okumura-Nakanishi; Motoki Saito; Hitoshi Niwa; Fuyuki Ishikawa
Journal:  J Biol Chem       Date:  2004-11-22       Impact factor: 5.157

2.  Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification.

Authors:  Debleena Pain; Gung-Wei Chirn; Christopher Strassel; Daniel M Kemp
Journal:  J Biol Chem       Date:  2005-01-06       Impact factor: 5.157

3.  Retroperitoneal seminoma in limited biopsies: morphologic criteria and immunohistochemical findings in 30 cases.

Authors:  Ming-Tse Sung; Gregory T MacLennan; Liang Cheng
Journal:  Am J Surg Pathol       Date:  2006-06       Impact factor: 6.394

4.  Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model.

Authors:  Katsumichi Iki; Parviz M Pour
Journal:  Pancreatology       Date:  2006-06-29       Impact factor: 3.996

Review 5.  OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.

Authors:  Chetana Ruangpratheep; Chanida Lohachittranond; Tara Poonpracha; Phaibul Punyarit
Journal:  J Med Assoc Thai       Date:  2005-11

Review 6.  Regulatory networks in embryo-derived pluripotent stem cells.

Authors:  Michele Boiani; Hans R Schöler
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

7.  Oct4 pseudogenes are transcribed in cancers.

Authors:  Guangli Suo; Jin Han; Xia Wang; Jingyu Zhang; Yannan Zhao; Yanhong Zhao; Jianwu Dai
Journal:  Biochem Biophys Res Commun       Date:  2005-10-04       Impact factor: 3.575

8.  Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells.

Authors:  Joon-Lin Chew; Yuin-Han Loh; Wensheng Zhang; Xi Chen; Wai-Leong Tam; Leng-Siew Yeap; Pin Li; Yen-Sin Ang; Bing Lim; Paul Robson; Huck-Hui Ng
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

9.  Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.

Authors:  T Tsukamoto; T Mizoshita; M Mihara; H Tanaka; Y Takenaka; Y Yamamura; S Nakamura; T Ushijima; M Tatematsu
Journal:  Histopathology       Date:  2005-06       Impact factor: 5.087

10.  Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components.

Authors:  Yuichi Sanada; Kazuhiro Yoshida; Masahiro Ohara; Mamoru Oeda; Kazuo Konishi; Yasuhiro Tsutani
Journal:  Pancreas       Date:  2006-03       Impact factor: 3.327

View more
  17 in total

1.  Expression of Oct-4 is significantly associated with the development and prognosis of colorectal cancer.

Authors:  Huan Zhou; Y U Hu; Weipeng Wang; Yong Mao; Jingjie Zhu; Bin Zhou; Jing Sun; Xueguang Zhang
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

2.  Expression levels of SOX2, KLF4 and brachyury transcription factors are associated with metastasis and poor prognosis in oral squamous cell carcinoma.

Authors:  Rumi Yoshihama; Koujiro Yamaguchi; Ikumi Imajyo; Mariko Mine; Naomi Hiyake; Naonari Akimoto; Yosuke Kobayashi; Satomi Chigita; Wataru Kumamaru; Tamotsu Kiyoshima; Yoshihide Mori; Tsuyoshi Sugiura
Journal:  Oncol Lett       Date:  2015-12-22       Impact factor: 2.967

Review 3.  Role of OCT4 in cancer stem-like cells and chemotherapy resistance.

Authors:  Ismail S Mohiuddin; Sung-Jen Wei; Min H Kang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-21       Impact factor: 5.187

4.  Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.

Authors:  Vinayak Nagaraja; Guy D Eslick
Journal:  J Gastrointest Oncol       Date:  2014-02

5.  Constructing a Mouse Oct4 Promoter/EGFP Vector, as a Whole-Cellular Reporter to Monitor the Pluripotent State of Cells.

Authors:  Reza Ghorbani; Abdolrahman Emamzadeh; Yahya Khazaie; Kianoush Dormiani; Kamran Ghaedi; Mohammad Rabbani; Mahboubeh Foruzanfar; Khadijeh Karbalaie; Fereshteh Karamali; Liana Lachinani; Abbas Kiani-Esfahani; Marzieh Nematollahi; Mohammad Hossein Nasr Esfahani
Journal:  Avicenna J Med Biotechnol       Date:  2013-01

6.  OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.

Authors:  Tieju Liu; Baocun Sun; Xiulan Zhao; Yanlei Li; Qiang Gu; Xueyi Dong; Fang Liu
Journal:  Int J Mol Sci       Date:  2014-10-28       Impact factor: 5.923

7.  Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary.

Authors:  Chantel Samardzija; Michael Quinn; Jock K Findlay; Nuzhat Ahmed
Journal:  J Ovarian Res       Date:  2012-11-21       Impact factor: 4.234

8.  Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway.

Authors:  Hai Lin; Li-Hua Sun; Wei Han; Tie-Ying He; Xin-Jian Xu; Kun Cheng; Cheng Geng; Li-Dan Su; Hao Wen; Xi-Yan Wang; Qi-Long Chen
Journal:  Mol Med Rep       Date:  2014-07-07       Impact factor: 2.952

9.  Expression of OCT4A: the first step to the next stage of urothelial bladder cancer progression.

Authors:  Wojciech Jóźwicki; Anna A Brożyna; Jerzy Siekiera
Journal:  Int J Mol Sci       Date:  2014-09-11       Impact factor: 5.923

10.  Relationship of Oct-4 to malignant stage: a meta-analysis based on 502 positive/high Oct-4 cases and 522 negative/low case-free controls.

Authors:  Beilong Zhong; Yan Lin; Yingrong Lai; Fangfang Zheng; Xiaobin Zheng; Rijiao Huang; Weilin Yang; Zhenguang Chen
Journal:  Oncotarget       Date:  2016-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.